Complications of diabetes: Screening for retinopathy and management of foot ulcers

Quality and Safety in Health Care

Volumn 9, Issue 2, 2000, Pages 137-141

  Melville, Arabella ^a   Richardson, Rachel ^a   McIntosh, Aileen ^c   O'Keeffe, Colin ^c   Mason, James ^b   Peters, Jean ^c   Hutchinson, Allen ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC RETINOPATHY; ECONOMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MASS SCREENING; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; STATISTICS; UNITED KINGDOM; UTILIZATION REVIEW;

COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC RETINOPATHY; GREAT BRITAIN; HUMANS; MASS SCREENING; OPHTHALMOSCOPY;

EID: 0034204229     PISSN: 09638172     EISSN: None     Source Type: Journal    
DOI: 10.1136/qhc.9.2.137     Document Type: Review

References (69)

1. NHS Centre for Reviews and Dissemination. Complications of diabetes: screening for retinopathy and management of foot ulcers. Effective Health Care 1999;5:1-12.
2. McIntosh A, Hutchinson A, Holme P, et al. Clinical guidelines and evidence review for type 2 diabetes: diabetic retinopathy; screening and management. London: Royal College of General Practitioners 2000 (in press).
3. Hutchinson A, McIntosh A, Feder G, et al. Clinical guidelines and evidence review for type 2 diabetes: prevention and management of foot problems. London: Royal College of General Practitioners, 2000 (in press).
4. Calman K. On the state of the public health. The annual report of the chief medical officer of the department of health for the year 1997. London: The Stationery Office, 1998.
5. Williams AS. Recommendations for desirable features of adaptive diabetes self-care equipment for visually impaired persons. Task force on adaptive diabetes for visually impaired persons. Diabetes Care 1994;17:451-2.
6. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
7. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of diabetic retinopathy. Clinical application of DRS findings. Ophthalmology 1998;116:297-303.
8. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98(suppl): 766-85.
9. Bachmann MO, Nelson S. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 1998;52:45-52.
10. Bachmann MO, Nelson S. Screening for diabetic retinopathy: a quantitative overview of the evidence, applied to the populations of health authorities and boards. Bristol: Health Care Evaluation Unit, University of Bristol, 1996.
11. Javitt JC, Aiello LP, Chiang Y, et al. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994;17:909-17.
12. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124: 164-9.
13. Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost-effectiveness of strategies for detecting diabetic retinopathy. Medical Care 1991;29:20-39.
14. Rohan TE, Frost CD, Wald NJ. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ 1989;299:1198-201.
15. Burnett S, Hurwitz B, Davey C, et al. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med 1998;15:S38-43.
16. Forrest RD, Jackson CA, Yudkin JS. Screening for diabetic retinopathy: comparison of a nurse and a doctor with retinal photography. Diabetes Res 1987;5:39-42.
17. Gibbins RL, Kinsella F, Young S, et al. Screening for diabetic retinopathy using 35mm colour transparency fundal photographs. Pract Diabetes 1994;11:203-6.
18. Gibbins RL, Owens DR, Allen JC, et al. Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia 1998;41:59-64.
19. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study. BMJ 1995;311:1131-5.
20. Taylor D, Fisher J, Jacob J, et al. The use of digital cameras in a mobile retinal screening environment. Diabet Med 1999;16:1-7.
21. Williams R, Nussey S, Humphry R, et al. Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. BMJ (Clin Res Ed) 1986;293:1140-2.
22. Moss SE, Klein R, Kessler SD, et al. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985;92:62-7.
23. Pugh JA, Jacobson JM, Van Heuven WA, et al. Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care 1993;16:889-95.
24. Lairson DR, Pugh JA, Kapadia AS, et al. Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care 1992;15:1369-77.
25. Klein R, Klein B, Neider MW, et al. Diabetic retinopathy as detected using ophthalmoscopy, a non-mydriatic camera and a standard fundus camera. Ophthalmology 1985;92: 485-491.
26. Kleinstein RN, Roseman JM, Herman WH, et al. Detection of diabetic retinopathy by optometrists. Journal of the American Optometric Association 1987;58:879-82.
27. Kinyoun JL, Martin DC, Fujimoto WY, et al. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci 1992;33: 1888-93.
28. Reenders K, de Nobel E, van den Hoogen H, et al. Screening for diabetic retinopathy by general practitioners. Scand J Primary Health Care 1992;10:306-9.
29. van de Kar W, van der Velden HG, van Weel C, et al. Diagnosing diabetic retinopathy by general practitioners and by a hospital physician. The use of fundus photos. Scand J Primary Health Care 1990;8:19-23.
30. Lienert RT. Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy. Aust NZ J Ophthalmol 1989;17:363-8.
31. Schatat AP, Hyman L, Leske MC, et al. Comparison of diabetic retinopathy detection by clinical examinations and photograph gradings. Barbados (West Indies) eye study group. Arch Ophthalmol 1993;111:1064-70.
32. Penman AD, Saddine JB, Hegazy M, et al. Screening for diabetic retinopathy: the utility of non mydriatic retinal photography in Egyptian adults. Diabet Med 1998;15:783-7.
33. Jude E, Ryan B, O'Leary J, et al. Pupillary dilatation and driving in diabetic patients. Diabet Med 1998;15:143-7.
34. Ryder RE, Kong N, Bates AS, et al. Instant electronic imaging systems are superior to Polaroid at detecting sight-threatening diabetic retinopathy. Diabet Med 1998;15:254-8.
35. Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. British Diabetic Association mobile retinal screening group. Diabet Med 1996;13:946-52.
36. Thompson CJ, Leese GP. The evaluation of mobile screening for diabetic retinopathy. Scott Med J 1995;40:5-7.
37. British Diabetic Association. Retinal photographic screening for diabetic eye disease. London: BDA, 1997.
38. The Royal College of Ophthalmologists. Guidelines for diabetic retinopathy. London: The Royal College of Ophthalmologists, 1997.
39. Leese GP, Ahmed S, Newton RW, et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ 1993;306:187-9.
40. Boulton A, Connor H, Cavanagh P. The foot in diabetes. Chichester: John Wiley, 1995.
41. Walters D, Gatling W, Mullee M, et al. The distribution and severity of diabetic foot disease: a community based study with comparison to a non-diabetic group. Diabet Med 1992; 9:354-8.
42. Apelqvist J, Larsson J, Agardh C. Longterm prognosis for diabetic patients with foot ulcers. J Intern Med 1993;233: 485-91.
43. Edmonds M, Blundell M, Morris M, et al. Improved survival of the diabetic foot: the role of the specialised foot clinic. Q J Medicine 1986;60:763-771.
44. McCabe C, Stevenson R, Dolan A. Evaluation of a diabetic foot screening and protection programme. Diabet Med 1998;15:80-4.
45. Ronnemaa T, Hamalainen H, Toikka T, et al. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care 1997;20: 1833-7.
46. Rettig B, Shrauger D, Recker R, et al. A randomized study of the effects of a home diabetes education program. Diabetes Care 1986;9:173-8.
47. Bloomgarden Z, Karmally W, Metzger J, et al. Randomized control trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care 1987;10:263-72.
48. Malone J, Snyder M, Anderson G, et al. Prevention of amputation by diabetic education. Am J Surg 1989;158: 520-4.
49. Barth R, Campbell L, Allen J, et al. Intensive education improves knowledge, compliance and foot problems in type 2 diabetes. Diabet Med 1991;8:111-17.
50. Kruger S, Guthrie D. Foot care: knowledge retention and self-care practices. The Diabetes Educator 1992;18:487-90.
51. Litzelman D, Slemenda C, Langefeld C, et al. Reduction of lower extremity clinical abnormalities in patients with non insulin dependent diabetes. Ann Intern Med 1993;119:36-41.
52. Uccioli L, Aldeghi A, Faglia E, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376-8.
53. Colagiuri S, Marsden L, Naidu V, et al. The use of orthotic devices to correct plantar callus in people with diabetes. Diabetes Res Clin Pract 1995;28:29-34.
54. Blackman J, Senseng D, Quinn L, et al. Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcer. Diabetes Care 1994; 17:322-5.
55. Foster A, Greenhill M, Edmonds M. Comparing two dressings in the treatment of diabetic foot ulcers. J Wound Care 1994;3:224-8.
56. Clever H, Dreyer M. Comparing two wound dressings for the treatment of neuropathic diabetic foot ulcers. 5th European Conference on Advances in Wound Management. London: Macmillan, 1996.
57. Donaghue VM, Chrzan JS, Rosenblum BI, et al. Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers. Advances in Wound Care 1998;11:114-19.
58. Ahroni J, Boyko E, Pecoraro R. Diabetic foot ulcer healing: extrinsic vs intrinsic factors. Wounds 1993;5:245-55.
59. Apelqvist J, Larsson J, Strenstrom A. Topical treatment of necrotic foot ulcers in diabetic patients: a comparative trial of Duoderm and MeZinc. Br J Dermatol 1990;123:787-92.
60. Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in treatment of diabetic planter ulcers. Controlled clinical trial. Diabetes Care 1989;12:384-8.
61. Steed D, Goslen J, Holloway G, et al. Randomised prospective double-blind trial in healing chronic diabetic foot ulcers: CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992;15:1598-604.
62. Steed D, Group DUS. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 1995;21:71-81.
63. Steed D, Ricotta J, Prendergast J, et aL Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. Diabetes Care 1995;18: 1-8.
64. Wieman T, Griffiths G, Polk H. Management of diabetic midfoot ulcers. Ann Surg 1992;215:627-32.
65. Holloway G, Steed D, DeMarco M, et al. A randomised controlled dose response trial of activated platelet supernatant, topical CT-102 in chronic, non-healing diabetic wounds. Wounds 1993;5:198-206.
66. Gough A, Clapperton M, Rolando N, et al. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 1997;350:855-9.
67. Martinez-de Jesus F, Morales-Guzman M, Castañeda M, et al. Randomised single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. Arch Med Res 1997;28:95-9.
68. Mulder G, Patt L, Sanders L, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-L-histidyl-L-lysine copper. Wound Repair Regeneration 1994;2:259-69.
69. Apelqvist J, Tennvall R. Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial. Acta Derm Venereol 1996;76:231-5.